China’s health care companies rush to raise capital during fight against coronavirus pandemic | South China Morning Post

China’s health care companies rush to raise capital during fight against coronavirus pandemic | South China Morning Post

More reads:

• Two years in, Hong Kong’s biotech experiment has been validated (Endpoints News)
• Flush with $165M IPO cash, Zentalis entices Tybourne, OrbiMed to fund a $20M China joint venture (Endpoints News)
• After red-hot IPO, Kintor eyes blockbuster drugs for prostate cancer, sex hormone-related hair loss (South China Morning Post)
• China’s health care companies rush to raise capital during fight against coronavirus pandemic (South China Morning Post)